Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by 10SixT3on Nov 12, 2018 12:37pm
103 Views
Post# 28960450

Traders Remain Short Marijuana ETF's Holdings

Traders Remain Short Marijuana ETF's Holdings

What Happened

The marijuana ETF rallied amid a slew of good news, including Michigan voters approving adult use of recreational cannabis, becoming the tenth state to do so. Missouri and Utah also voted to approve various medical marijuana initiatives while some other states took steps toward loosening cannabis regulations.

While there was plenty of good news driving MJ and its components higher for part of last week, data confirm that traders remain heavily short cannabis stocks, such as Canopy Growth (NYSE: CGC), Aurora Cannabis Inc. (NYSE: ACB), Tilray Inc. (NASDAQ: TLRY) and Cronos Group (NASDAQ: CRON).

“With the cannabis sector rallying in 2018, short sellers have added almost $1.4 billion of exposure since mid-year, hoping for a reversal in what they believe to be an over-heated and over-valued sector,” according to S3 Partners. “Short interest is now $3.35 billion in the 141 securities we track in our cannabis basket. While short interest in the sector continues to grow in 2018, exposure is very extremely concentrated, with 94% of the short interest in only 10 securities.”

Why It's Important

The $710.47 million MJ tracks the Prime Alternative Harvest Index. The four aforementioned stocks are MJ's top four holdings, combining for roughly 31 percent of the fund's weight. Forty stocks are found on the ETF's roster.

While shorting cannabis stocks can be rewarding, it's far from an inexpensive, low-risk endeavor.

“While short selling and timing the cannabis market may be a profitable endeavor, there is a steep cost to enter the trade. Overall stock borrow costs are very high, with the average stock borrow fee in the sector being 13.44% fee and short sellers spending nearly $1.3 million per day in stock borrow financing costs,” according to S3.

What's Next

Barring a lengthy rally by marijuana stocks, it's likely some traders will continue tempting fate and approaching the sector from the short side.

“We should expect short selling in the cannabis sector to continue to grow, providing a slight counterbalance to the long buying frenzy and also providing trading liquidity in some of the less broadly traded securities,” said S3.

 
Bullboard Posts